GlassScriptPhysician profile
Pauline M Heuser
NPI 1134548456
$3,534.64
in general payments reported to CMS, 2019-2025
19 companies · $760 in 2025
The $760 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.49 · 2022: $346 · 2023: $1,363 · 2024: $975 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,479 · Education: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,478.82 |
| Education | $618.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $711.17 | 2022-2025 | Tremfya |
| Abbvie INC. | $593.30 | 2022-2025 | |
| Lilly USA, LLC | $349.90 | 2021-2025 | Olumiant, Taltz, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $263.38 | 2022-2025 | Sotyktu |
| Ucb, INC. | $253.33 | 2022-2025 | Bimzelx, Cimzia |
| Leo Pharma INC. | $251.08 | 2022-2025 | Adbry, Anzupgo |
| Dermavant Sciences, INC. | $222.66 | 2023-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $188.48 | 2023-2025 | Winlevi, Absorica Ld, Odomzo |
| Pfizer INC. | $156.57 | 2021-2024 | |
| Genzyme Corporation | $124.20 | 2022-2024 | |
| Arcutis Biotherapeutics, INC. | $111.09 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $106.22 | 2022-2025 | Dupixent |
| Incyte Corporation | $74.69 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $28.44 | 2025 | Nemluvio |
| Pacira Pharmaceuticals Incorporated | $26.77 | 2025 | Exparel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $23.44 | 2021 | |
| Botanix Sb INC | $23.17 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.76 | 2024 | Cabtreo |
| Organon LLC | $8.99 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pauline Heuser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.